All In Biotech

Drug Trial Radar · NCT06660173

A Study of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus (T2DM)

A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM

Last checked: Nov 20, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 409 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

409

Actual

Start

Nov 7, 2024

Primary completion

Oct 6, 2025

Study completion Nov 10, 2026

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 28, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to assess the dose-response relationship of maridebart cafraglutide on glucose control compared with placebo.

Conditions

  • Type 2 Diabetes Mellitus (T2DM)

Interventions

  • Maridebart CafraglutideDrug

    Solution for subcutaneous injection.

  • PlaceboDrug

    Solution for subcutaneous injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline to Week 24 in Hemoglobin A1c (HbA1c)Time frame: Baseline to Week 24

Locations

96 sites in 14 countries. Site status is shown where the registry gives one.

  • Accel Research Site - Birmingham Clinical Research Unit

    Birmingham, Alabama

  • Anaheim Clinical Trials

    Anaheim, California

  • Hope Clinical Research LLC

    Canoga Park, California

  • Orange County Research Center

    Lake Forest, California

  • San Jose Clinical Trials

    San Jose, California

  • Northeast Research Institute - Neri

    Fleming Island, Florida

  • New Horizon Research Center

    Miami, Florida

  • Florida Institute for Clinical Research

    Orlando, Florida

  • Conquest Research - Winter Park

    Winter Park, Florida

  • Accel Research Site - Neurostudies

    Decatur, Georgia

  • Cedar Crosse Research and Health Care

    Chicago, Illinois

  • Tandem Clinical Research - Marrero

    Marrero, Louisiana

  • DM Clinical - Detroit

    Southfield, Michigan

  • Montana Medical Research

    Missoula, Montana

  • Physicians East

    Greenville, North Carolina

  • Diabetes and Endocrinology Associates of Stark County Inc

    Canton, Ohio

  • Alliance for Multispecialty Research

    Norman, Oklahoma

  • Trial Management Associates - Myrtle Beach

    Myrtle Beach, South Carolina

  • FutureSearch Trials of Neurology

    Austin, Texas

  • Velocity Clinical Research - Dallas

    Dallas, Texas

  • DM Clinical Research - Cyfair Clinical Research Center

    Houston, Texas

  • Southern Endocrinology Associates PA

    Mesquite, Texas

  • Be Well Clinical Studies

    Round Rock, Texas

  • Diabetes and Glandular Disease Clinic

    San Antonio, Texas

  • DM Clinical Research - Martin Diagnostic Clinic

    Tomball, Texas

  • Charlottesville Medical Research Center

    Charlottesville, Virginia

  • Manassas Clinical Research Center Inc

    Manassas, Virginia

  • Eastside Research Associates Health Research

    Redmond, Washington

  • Medizinische Universitaet Graz

    Graz, Austria

  • Krankenhaus der Barmherzigen Brueder Linz

    Linz, Austria

  • Universitaetsklinikum Allgemeines Krankenhaus Wien

    Vienna, Austria

  • Klinik Hietzing

    Vienna, Austria

  • Laiko General Hospital of Athens

    Athens, Greece

  • Athens Medical Center S.A - Iatriko Amarousiou

    Marousi, Greece

  • Athens Medical Center- Iatriko Paleou Falirou

    Palaió Fáliro, Greece

  • Geniko Nosokomeio Peiraia Tzaneio

    Piraeus, Greece

  • General Hospital of Thessaloniki Ahepa

    Thessaloniki, Greece

  • Thermi Clinic S.A.

    Thessaloniki, Greece

  • Queen Mary Hospital, The University of Hong Kong

    Hong Kong, Hong Kong

  • Lausmed Kft

    Baja, Hungary

Showing 40 of 96 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.